Form 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

January 24, 2008

Date of Report (Date of earliest event reported)

APPLERA CORPORATION

(Exact name of registrant as specified in its charter)

 

Delaware   001-04389   06-1534213

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

301 Merritt 7  
Norwalk, Connecticut   06851
(Address of principal executive offices)   (Zip Code)

(203) 840-2000

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 



Item 2.02. Results of Operations and Financial Condition.

(a)        On January 24, 2008, Applera Corporation (“Applera”) announced financial results for Applera and its business units for the second quarter of its 2008 fiscal year. Attached hereto as Exhibit 99.1 and incorporated by reference herein is the text of a press release issued on January 24, 2008, with respect to financial results for the second quarter of fiscal year 2008 of Applera and Applera’s Applied Biosystems Group, and attached hereto as Exhibit 99.2 and incorporated by reference herein is the text of a press release issued on January 24, 2008, with respect to financial results for the second quarter of fiscal year 2008 of Applera and Applera’s Celera Group.

 

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

The following exhibits are filed with this Report:

 

Exhibit No.    Description

99.1

   Press Release issued January 24, 2008, with respect to financial results for Applera and Applera’s Applied Biosystems Group.

99.2

   Press Release issued January 24, 2008, with respect to financial results for Applera and Applera’s Celera Group.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

APPLERA CORPORATION
By:  

/s/ Dennis L. Winger

  Dennis L. Winger
  Senior Vice President and Chief Financial Officer

Dated: January 24, 2008


EXHIBIT INDEX

 

Exhibit No.   Description

99.1

  Press Release issued January 24, 2008, with respect to financial results for Applera and Applera’s Applied Biosystems Group.

99.2

  Press Release issued January 24, 2008, with respect to financial results for Applera and Applera’s Celera Group.